• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now

    10/31/23 7:00:00 AM ET
    $AGBA
    $AMPE
    $CING
    $COCH
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGBA alert in real time by email

    MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1

    November 1, 2023

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 - 9:35

    AGBA Group Holding Limited (NASDAQ:AGBA)

    Keynote speaker: Mr. Wing-Fai Ng, Group President of AGBA Group

    9:40 - 10:10

    Battery Mineral Resources Corp., (OTCQB:BTRMF) (TSXV:BMR)

    KeKeynote speaker: Martin Kostuik, President / CEO

    10:15 - 10:45

    Envoy Medical, Inc. (NASDAQ:COCH)

    Keynote speaker: Brent Lucas, CEO & David R. Wells, CFO

    10:50 - 11:20

    Houston Natural Resources Corp. (OTC:HNRC)

    Keynote speaker: Frank Kristan, Chairman & CEO

    11:25 - 11:55

    Electronic Servitor Publication Network Inc. (OTCQB:XESP)

    Keynote speaker: Peter Hager, President / CEO

    12:00 - 12:30

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    12:35 - 1:05

    Ocean Biomedical, Inc. (NASDAQ:OCEA)

    Keynote speakers:

    Dr. Chirinjeev Kathuria, Co-founder / Chairman,

    Elizebeth Ng, CEO,

    Dr. Jonathan Kurtis, Scientific Co-founder & Director of the MD/PhD program Brown University,

    Gurinder Kalra, CFO,

    Daniel Behr, EVP of Academic Partnerships,

    Dr. Inderjote Kathuria, Chief Strategy Officer

    1:10 - 1:40

    GPO Plus, Inc. (OTCQB:GPOX)

    Keynote speaker: Brett Pojunis, President / CEO

    Postponed to December 6

    Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)

    Keynote speaker: David Mehalick, President / CEO

    2:20 - 2:50

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:55 - 3:05

    Renforth Resources, Inc. (OTCQB:RFHRF) (CSE:RFR)

    Keynote speaker: Nicole Brewster, President & CEO

    3:10 - 3:20

    Ideal Power (NASDAQ:IPWR)

    Keynote speaker: Dan Brdar, President / CEO, & Tim Burns, CFO

    3:25 - 3:35

    Steppe Gold, Ltd. (OTCQX:STPGF) (TSX:STGO)

    Keynote speakers: Aneel Singh, Exec. VP & Director

    3:40 - 3:50

    NeuroMetrix, Inc. (NASDAQ:NURO)

    Keynote speaker: Dr. Shai Gozani, CEO & Thomas Higgins, CFO

    3:55 - 4:05

    RedCloud Technologies, a Private Company

    Keynote speaker: Justin Floyd, CEO

    Day 2

    November 2, 2023

    10:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    10:15 - 10:45

    Sonim Technologies, Inc. (NASDAQ:SONM)

    Keynote speaker: Hao Liu, CEO

    10:50 - 11:20

    Quantum Computing Inc., (NASDAQ:QUBT)

    Keynote speakers: Robert Liscouski, CEO, & Chris Boehmler, CFO

    11:25 - 11:55

    Gold Terra Resource Corp. (OTCQX:YGTFF) (TSXV:YGT)

    Keynote speaker: Gerald Sylvain Panneton, CEO

    12:00 - 12:30

    Independence Contract Drilling, Inc. (NYSE:ICD)

    Keynote speaker: Anthony Gallegos, President / CEO & Director

    12:35 - 1:05

    BioHarvest Sciences Inc. (OTCQB:CNVCF) (CSE:BHSC)

    Keynote speaker: Ilan Sobel, CEO

    1:10 - 1:40

    Ampio Pharmaceuticals, Inc. (NYSE:AMPE)

    Keynote speaker: Michael Martino, CEO & Director

    1:45 - 2:15

    Medicus Pharma Ltd. (TSXV:MDCX)

    Keynote speaker: Carolyn Bonner, President

    Postponed to December 6

    Cingulate Inc. (NASDAQ:CING)

    Keynote speaker: Shane Schaffer, CEO

    2:55 - 3:05

    Loop Industries, Inc. (NASDAQ:LOOP)

    Keynote speaker: Kevin C. O'Dowd, VP Communications

    3:10 - 3:20

    Theriva Biologics Inc., (NYSE:TOVX)

    Keynote speaker: Dr. Manel Cascallo', General Director

    3:25 - 3:35

    Alpha Tau Medical, Inc. (NASDAQ:DRTS)

    eynote speaker: Raphi Levy, CFO

    3:55 - 4:05

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AMPE
    $CING
    $COCH

    CompanyDatePrice TargetRatingAnalyst
    Quantum Computing Inc.
    $QUBT
    1/15/2026$22.00Buy
    Rosenblatt
    Quantum Computing Inc.
    $QUBT
    12/17/2025$12.00Neutral
    Wedbush
    Quantum Computing Inc.
    $QUBT
    9/18/2025$24.00Buy
    Lake Street
    Quantum Computing Inc.
    $QUBT
    7/2/2025$15.00Neutral
    Cantor Fitzgerald
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    Cingulate Inc.
    $CING
    1/10/2025$12.00Buy
    ROTH MKM
    GeoVax Labs Inc.
    $GOVX
    11/11/2024$15.00Buy
    Alliance Global Partners
    More analyst ratings

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer King Steven R. was granted 11,740 shares, increasing direct ownership by 8,097% to 11,885 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    1/21/26 4:30:46 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Conte Lisa A was granted 28,592 shares, increasing direct ownership by 4,293% to 29,258 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    1/21/26 4:30:40 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Wolin Jonathan S. was granted 11,740 shares, increasing direct ownership by 5,929% to 11,938 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    1/21/26 4:30:27 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rosenblatt initiated coverage on Quantum Computing with a new price target

    Rosenblatt initiated coverage of Quantum Computing with a rating of Buy and set a new price target of $22.00

    1/15/26 8:40:11 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Wedbush initiated coverage on Quantum Computing with a new price target

    Wedbush initiated coverage of Quantum Computing with a rating of Neutral and set a new price target of $12.00

    12/17/25 9:27:03 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Lake Street initiated coverage on Quantum Computing with a new price target

    Lake Street initiated coverage of Quantum Computing with a rating of Buy and set a new price target of $24.00

    9/18/25 7:59:36 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing

    NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held February 5th are now available for on-demand viewing. Individual investors, institutional investors, advisors, and analysts are invited to attend.REGISTER AND VIEW PRESENTATIONS HERE The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section. Select companies are accepting 1x1 management meeting requests through February 10th. Please Schedule 1x1 Meetings here Febru

    2/6/26 8:35:00 AM ET
    $ADGM
    $COCH
    Medical/Dental Instruments
    Health Care
    Industrial Specialties

    Coeptis Receives Shareholder Approval Towards Z Squared Merger

    WEXFORD, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, today announced that its shareholders have voted to approve the previously announced merger with Z Squared Inc. The transaction was approved on January 30, 2026, by Coeptis' shareholders. In connection with the consummation of the business combination, Z Squared will become a wholly owned subsidiary of Coeptis. The transaction remains subject to satisfaction of the remaining conditions to closing. Additional details regarding the shareholder vote and the proposed merger are included in the Company's Form 8-K f

    2/5/26 4:00:00 PM ET
    $COEP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026

    - Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of Ophthalmology (APAO) Congress in Hong Kong on Saturday, 07 February 2026 – - Preclinical data will highlight synergistic antitumor activity for the combination of topotecan and VCN-01 that may improve outcomes in refractory retinoblastoma patients with difficult-to-treat vitreous seeds - ROCKVILLE, Md. and BARCELONA, Spain, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE:TOVX), ("Theriva" or the "Company"), a diversified clinical-stage company developing therapeutics designed to tre

    2/3/26 8:00:00 AM ET
    $TOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    SEC Filings

    View All

    Sonim Technologies Inc. filed SEC Form 8-K: Leadership Update

    8-K - DNA X, Inc. (0001178697) (Filer)

    2/5/26 8:00:43 AM ET
    $SONM
    Telecommunications Equipment
    Utilities

    Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)

    2/4/26 4:30:26 PM ET
    $COEP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Quantum Computing Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Quantum Computing Inc. (0001758009) (Filer)

    2/3/26 4:11:34 PM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hart Spencer bought $66,070 worth of shares (50,000 units at $1.32), increasing direct ownership by 14% to 410,370 units (SEC Form 4)

    4 - Loop Industries, Inc. (0001504678) (Issuer)

    11/12/25 4:33:21 PM ET
    $LOOP
    Major Chemicals
    Industrials

    Chief Medical Officer Mckee Kelly T. Jr. bought $742 worth of shares (1,107 units at $0.67), increasing direct ownership by 46% to 3,494 units (SEC Form 4)

    4 - GeoVax Labs, Inc. (0000832489) (Issuer)

    8/8/25 3:13:56 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hart Spencer bought $33,100 worth of shares (20,000 units at $1.66), increasing direct ownership by 6% to 360,370 units (SEC Form 4)

    4 - Loop Industries, Inc. (0001504678) (Issuer)

    8/7/25 8:10:14 PM ET
    $LOOP
    Major Chemicals
    Industrials

    $AGBA
    $AMPE
    $CING
    $COCH
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum Computing Inc. Confirms Dr. Yuping Huang as Chief Executive Officer to Lead Global Growth

    HOBOKEN, N.J., Dec. 17, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today announced a leadership update with the appointment of Dr. Yuping Huang as Chief Executive Officer ("CEO"), effective January 1st, 2026. Dr. Huang was appointed as QCi's Interim CEO on April 11, 2025. This appointment comes as part of QCi's ongoing focus on growth and scaling its quantum photonics systems for industrial and commercial use. Dr. Huang's appointment marks a pivotal moment as QCi moves from prototype development and small-batch manufacturing toward industrial-scale manufacturing production. The

    12/17/25 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to build a pipeline of next-generation products, today announced financial results for the quarter ended September 30, 2025, and provided recent corporate highlights. Recent Highlights (Post-Q3) FDA Accepts NDA for CTx-1301; PDUFA Date Set for May 31, 2026In October of 2025, the U.S. Food and Drug Administration (FDA) accepted Cingulate's New Drug Application

    11/13/25 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

    Appointment builds on recent FDA acceptance of New Drug Application for review and advances Cingulate's transition toward commercialization pending FDA approval Company also strengthens its cash position by completing a $6 million financing KANSAS CITY, Kan., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ (PTR™) drug-delivery platform, today announced the appointment of Bryan Downey as Chief Commercial Officer, following the U.S. Food and Drug Administration's (FDA) acceptance of Cingulate's New Drug Application (ND

    11/10/25 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cingulate Inc.

    SC 13G/A - Cingulate Inc. (0001862150) (Subject)

    11/14/24 7:21:05 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Coeptis Therapeutics Holdings Inc.

    SC 13G/A - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)

    11/14/24 3:59:49 PM ET
    $COEP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Financials

    Live finance-specific insights

    View All

    QuantumSpeed Technology Emerges as a Critical Advantage in Modern Defense Operations

    Military demand for faster, software-defined capabilities drives adoption of next-generation platforms Market News Updates News Commentary NEW YORK, Jan. 7, 2026 /PRNewswire/ -- QuantumSpeed technology represents a compelling investment opportunity tied directly to the modernization of global defense infrastructure and the premium placed on speed-driven decision advantage, leading to opportunity for active companies such as VisionWave Holdings Inc. (NASDAQ:VWAV), D-Wave Quantum Inc. (NYSE:QBTS), Rigetti Computing, Inc. (NASDAQ:RGTI), IonQ (NYSE:IONQ), Quantum Computing Inc. (NASDAQ:QUBT).  Defense operations are rapidly shifting toward real-time, data-intensive environments where millisecon

    1/7/26 9:00:00 AM ET
    $IONQ
    $QBTS
    $QUBT
    EDP Services
    Technology
    Computer Software: Prepackaged Software

    Quantum Computing Inc. Reports Third Quarter 2025 Financial Results

    HOBOKEN, N.J., Nov. 14, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, integrated photonics and quantum optics technology company, today released financial results for the three and nine-month periods ended September 30, 2025. Dr. Yuping Huang, Interim Chief Executive Officer of QCi, commented, "The third quarter marked another important step forward for QCi as we strengthened our balance sheet, deepened commercial and government relationships, and advanced our roadmap toward scalable quantum and photonic manufacturing. Revenues increased 280% year-over-year for the three months ended September 30, 2025, reflecting our sales progress and in

    11/14/25 4:05:00 PM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Ideal Power Reports Third Quarter 2025 Financial Results

    AUSTIN, Texas, Nov. 13, 2025 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reports results for its third quarter ended September 30, 2025. "I'm excited to have joined Ideal Power and thrilled by the strong foundation in place for growth. Our first design win customer successfully completed testing of the updated prototype solid-state circuit breakers (SSCBs) and we are currently working with them on the finalization of their first product design," said David Somo, President and Chief Executive Officer of Ideal P

    11/13/25 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology